• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻塞性睡眠呼吸暂停的体重减轻:药物和手术治疗

Weight Loss for Obstructive Sleep Apnea: Pharmacological and Surgical Management.

作者信息

Kim Beomsoo, Choi Ji Ho

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Republic of Korea.

Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital, Bucheon, Republic of Korea.

出版信息

J Rhinol. 2023 Mar;30(1):1-5. doi: 10.18787/jr.2023.00010. Epub 2023 Mar 30.

DOI:10.18787/jr.2023.00010
PMID:39664699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11524361/
Abstract

Obstructive sleep apnea (OSA) is a relatively common sleep disorder characterized by repetitive narrowing or obstruction of the upper airway, including the nasal cavity, pharynx, and larynx, during sleep. OSA can cause a variety of symptoms and/or complications, such as excessive daytime sleepiness, reduced concentration, hypertension, type II diabetes, and stroke. Accordingly, an accurate diagnosis and appropriate treatments are required for OSA. Obesity is an important risk factor for OSA and is characterized by the abnormal accumulation of fat in the body, including the upper airway. When the body weight increases, adipose tissue accumulates in the pharynx, which can narrow the diameter of the upper airway and lead to dysfunction of the pharynx dilator muscles. These changes caused by weight gain can cause or exacerbate OSA. Various therapeutic options exist for patients with overweight or obesity, including diet, behavioral modifications, exercise, pharmacological treatments, and surgical procedures. Of these, diet, behavioral modifications, and exercise constitute the first-line management for obesity. However, their results are relatively unsatisfactory, and pharmacotherapy and bariatric surgery are generally implemented in obese patients with OSA. Therefore, the purpose of this paper is to review pharmacological and surgical management strategies for obesity that are currently commonly used in overweight or obese adult patients with OSA.

摘要

阻塞性睡眠呼吸暂停(OSA)是一种相对常见的睡眠障碍,其特征是在睡眠期间上呼吸道(包括鼻腔、咽部和喉部)反复变窄或阻塞。OSA可导致多种症状和/或并发症,如白天过度嗜睡、注意力不集中、高血压、2型糖尿病和中风。因此,OSA需要准确的诊断和适当的治疗。肥胖是OSA的一个重要危险因素,其特征是身体(包括上呼吸道)脂肪异常堆积。体重增加时,脂肪组织在咽部堆积,可使上呼吸道直径变窄,并导致咽部扩张肌功能障碍。体重增加引起的这些变化可导致或加重OSA。超重或肥胖患者有多种治疗选择,包括饮食、行为改变、运动、药物治疗和手术程序。其中,饮食、行为改变和运动构成肥胖的一线管理方法。然而,它们的效果相对不理想,药物治疗和减肥手术通常应用于患有OSA的肥胖患者。因此,本文的目的是综述目前超重或肥胖成年OSA患者常用的肥胖药物和手术管理策略。

相似文献

1
Weight Loss for Obstructive Sleep Apnea: Pharmacological and Surgical Management.阻塞性睡眠呼吸暂停的体重减轻:药物和手术治疗
J Rhinol. 2023 Mar;30(1):1-5. doi: 10.18787/jr.2023.00010. Epub 2023 Mar 30.
2
Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis.阻塞性睡眠呼吸暂停患者的多导睡眠图:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(13):1-38. Epub 2006 Jun 1.
3
[Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women].[女性阻塞性睡眠呼吸暂停诊断与治疗专家共识]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Jun 12;47(6):509-528. doi: 10.3760/cma.j.cn112147-20240206-00072.
4
Abdominal fat and sleep apnea: the chicken or the egg?腹部脂肪与睡眠呼吸暂停:孰因孰果?
Diabetes Care. 2008 Feb;31 Suppl 2(7):S303-9. doi: 10.2337/dc08-s272.
5
Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea.上呼吸道肌肉反应性增强是无睡眠呼吸暂停的超重/肥胖个体的一个显著特征。
Am J Respir Crit Care Med. 2014 Oct 15;190(8):930-7. doi: 10.1164/rccm.201404-0783OC.
6
Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management.阻塞性睡眠呼吸暂停的管理和药物相关症状管理的综述。
Medicina (Kaunas). 2021 Oct 28;57(11):1173. doi: 10.3390/medicina57111173.
7
The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea. An Official American Thoracic Society Clinical Practice Guideline.体重管理在成人阻塞性睡眠呼吸暂停治疗中的作用。美国胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 15;198(6):e70-e87. doi: 10.1164/rccm.201807-1326ST.
8
Gender differences in the expression of sleep-disordered breathing : role of upper airway dimensions.睡眠呼吸障碍表现中的性别差异:上气道尺寸的作用。
Chest. 2001 Nov;120(5):1442-7. doi: 10.1378/chest.120.5.1442.
9
Diagnosis and Management of Obstructive Sleep Apnea: A Review.阻塞性睡眠呼吸暂停的诊断和治疗:综述。
JAMA. 2020 Apr 14;323(14):1389-1400. doi: 10.1001/jama.2020.3514.
10
Weight loss for obstructive sleep apnea: the optimal therapy for obese patients.阻塞性睡眠呼吸暂停的体重减轻:肥胖患者的最佳治疗方法。
J Am Diet Assoc. 1994 Nov;94(11):1291-5. doi: 10.1016/0002-8223(94)92462-7.

本文引用的文献

1
A comprehensive review of obstructive sleep apnea.阻塞性睡眠呼吸暂停的全面综述。
Sleep Sci. 2021 Apr-Jun;14(2):142-154. doi: 10.5935/1984-0063.20200056.
2
Obstructive sleep apnea remission following bariatric surgery: a national registry cohort study.减重手术后阻塞性睡眠呼吸暂停缓解:全国登记队列研究。
Surg Obes Relat Dis. 2021 Sep;17(9):1576-1582. doi: 10.1016/j.soard.2021.05.021. Epub 2021 May 21.
3
2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea.《2020年韩国肥胖研究学会韩国肥胖管理指南》
J Obes Metab Syndr. 2021 Jun 30;30(2):81-92. doi: 10.7570/jomes21022.
4
Diagnosis and Management of Obstructive Sleep Apnea: A Review.阻塞性睡眠呼吸暂停的诊断和治疗:综述。
JAMA. 2020 Apr 14;323(14):1389-1400. doi: 10.1001/jama.2020.3514.
5
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.基于文献的分析估计全球阻塞性睡眠呼吸暂停的患病率和负担。
Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9.
6
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.胰高血糖素样肽-1 的作用机制与治疗应用。
Cell Metab. 2018 Apr 3;27(4):740-756. doi: 10.1016/j.cmet.2018.03.001.
7
Recent trends in the prevalence of underweight, overweight, and obesity in Korean adults: The Korean National Health and Nutrition Examination Survey from 1998 to 2014.韩国成年人中体重过轻、超重和肥胖患病率的近期趋势:1998年至2014年韩国国民健康与营养检查调查
J Epidemiol. 2017 Sep;27(9):413-419. doi: 10.1016/j.je.2016.08.014. Epub 2017 Apr 15.
8
Impact of Weight Loss Management in OSA.OSA 中体重管理的影响。
Chest. 2017 Jul;152(1):194-203. doi: 10.1016/j.chest.2017.01.027. Epub 2017 Feb 6.
9
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial.利拉鲁肽3.0毫克对肥胖合并中度或重度阻塞性睡眠呼吸暂停患者的影响:SCALE睡眠呼吸暂停随机临床试验
Int J Obes (Lond). 2016 Aug;40(8):1310-9. doi: 10.1038/ijo.2016.52. Epub 2016 Mar 23.
10
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.利拉鲁肽 3.0 毫克在体重管理中的随机、对照试验。
N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892.